Treatment Of Covid 19 In Hospitals
COVID-19 is caused by the novel coronavirus, SARS-CoV-2. Symptoms include fever, cough, fatigue,
shortness of breath, loss of appetite, loss of taste or smell, and diarrhea. Most people who develop
COVID-19 have mild symptoms which will (and should) be managed reception . However, some people
develop serious illness and require hospital care. About 25 to 33% of these who are hospitalized need
medical care , but most hospitalised people recover.
Unfortunately, there is no known cure for COVID-19.Search for effective treatment is still ongoing , still
there are some promising therapies currently in use for severely ill COVID-19 patients.
Hospital Care for Coronavirus.
A person who is persistently in need of breath may have hospitalization . Shortness of breath indicates
the lungs aren’t delivering enough oxygen to the remainder of the body; without treatment, oxygen levels
may fall and cause organ failure.
Hospital care for covid 19 focuses on supportive care, or treatment to support the body’s vital organs.
Hospital staff monitor patients’ vital signs (heart rate, vital sign , number of breaths per minute) to
observe for any developing problems.
Looking for a Coronavirus Cure
Clinical studies show the antibodies can reduce hospitalizations in patients with mild to moderate
Some existing drugs may help hospitalized patients with COVID-19, so doctors are using a kind of
treatments. Patients may receive the following drugs:
COVID-19 is caused by an epidemic , so antibiotics—which kill bacteria, not viruses—cannot cure the
disease. But, some antibiotics like azithromycin (Zithromax) exhibit antiviral properties. Treating these
infections with antibiotics can ease the general strain on the body.
Remdesivir (Veklury), an antiviral which will kill SARS-CoV-2 during a Petri dish under experimental
conditions. Is approved for hospitalized patients 12 and older, even if they are not enrolled in clinical
trials. A clinical test of another antiviral , EIDD-2801, began in late April 2020.
Treating patients on ventilators with the steroid dexamethasone improved outcomes—reducing deaths
by up to a third, but had no effect on hospitalized patients who did not need either of these therapies.
DMARDS (disease-modifying antirheumatic drugs).
Ongoing clinical trials to check the effect of medicine currently prescribed to suppress the system , within
the hopes of tamping down widespread inflammation that happens in severely ill patients. Guidelines
include administering a mixture of tocilizumab (Actemra) with dexamethasone to patients whose oxygen
levels are rapidly declining.
Intensive Care and Ventilator Treatment
If a patient’s condition worsens despite supportive hospitalization , the patient could also be transferred
to the medical care unit (ICU). Patients in the ICU are monitored more closely than other hospitalized
If the patient cannot breathe well, doctors may recommend intubation. Critical care providers administer
drugs therefore the patient remains sleepy and cozy . When the patient improves, the healthcare team
will gradually wean the patient off the ventilator.
Other Treatments Include
Vitamin c which is prescribed to boost immunity….also heparin to help prevent blood clots seen in covid
19 patients also zinc sulfate is also prescribed for its anti-inflammatory and antioxidant features and for
the function that it strengthens the integrity of the epithelium in cells.